Atlas Trials

A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women

Clinical trial NCT01250145 · COMPLETED

Trial details

NCT number
NCT01250145
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Osteoporosis, Postmenopausal
Start date
2010-11-01
Primary completion
2011-05-01
Enrollment
251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.